MedicineWatch US
Class II Recall

ProRx LLC

Product
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
Reason
Lack of Assurance of Sterility
Classification
Class II
Status
Ongoing
Lot
Lot # ProRx040924-1, BUD 10/08/2024
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
ProRx LLC — Class II Recall | MedicineWatch US